Lipoic Acid for Neuroprotection in Secondary Progressive Multiple Sclerosis

被引：0
|
作者：
Spain, Rebecca [1 ,2 ]
Murchison, Charles
Horak, Fay [1 ]
Simon, Jack
Bourdette, Dennis [1 ]
机构：
[1] OHSU, Portland, OR USA
[2] Portland VA Hlth Care Syst, Neurol, Portland, OR USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.373
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lipoic Acid for Neuroprotection in Secondary Progressive Multiple Sclerosis
    Spain, Rebecca
    Murchison, Charles
    Horak, Fay
    Simon, Jack
    Bourdette, Dennis
    NEUROLOGY, 2016, 86
  • [2] Lipoic acid for neuroprotection in secondary progressive multiple sclerosis: results of a randomised placebo-controlled pilot trial.
    Spain, R. I.
    Powers, K.
    Murchison, C.
    Heriza, E.
    Horak, F. B.
    Simon, J.
    Bourdette, D. N.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 81 - 81
  • [3] Effects of lipoic acid on walking performance, gait, and balance in secondary progressive multiple sclerosis
    Loy, Bryan D.
    Fling, Brett W.
    Horak, Fay B.
    Bourdette, Dennis N.
    Spain, Rebecca I.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 41 : 169 - 174
  • [4] The Pharmacokinetics of Lipoic Acid at Baseline and 48 Weeks in Secondary Progressive Multiple Sclerosis Patients
    Bittner, Frank
    Murchison, Charles
    Bourdette, Dennis
    Spain, Rebecca
    ANNALS OF NEUROLOGY, 2016, 80 : S117 - S117
  • [5] A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis
    Furby, J.
    Hayton, T.
    Smith, K. J.
    Altmann, D.
    Brenner, R.
    Chataway, J.
    Fox, N. C.
    Hughes, R. A. C.
    Miller, D. H.
    Kapoor, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S228 - S228
  • [6] A Randomized Controlled Trial of Neuroprotection with Lamotrigine in Secondary Progressive Multiple Sclerosis
    Kapoor, Raju
    Furby, Julian
    Hayton, Thomas
    Smith, Kenneth
    Altmann, Daniel
    Brenner, Robert
    Chataway, Jeremy
    Hughes, Richard
    Miller, David
    NEUROLOGY, 2010, 74 (09) : A193 - A193
  • [7] Role of lipoic acid in multiple sclerosis
    Xie, Hongsheng
    Yang, Xiufang
    Cao, Yuan
    Long, Xipeng
    Shang, Huifang
    Jia, Zhiyun
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (03) : 319 - 331
  • [8] Outcomes of a phase II randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis
    Kapoor, R.
    Furby, J.
    Hayton, T.
    Smith, K. J.
    Altmann, D. R.
    Brenner, R.
    Chataway, J.
    Hughes, R. A. C.
    Hunter, K.
    Miller, D. H.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S27 - S28
  • [9] Small Effect of Lipoic Acid on Timed Up and Go Walking Speed in People with Secondary-Progressive Multiple Sclerosis: A Pilot Study
    Loy, Bryan D.
    Fling, Brett W.
    Horak, Fay B.
    Bourdette, Dennis
    Spain, Rebecca I.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 68 - 69
  • [10] Lipoic acid in multiple sclerosis: a pilot study
    Yadav, V
    Marracci, G
    Lovera, J
    Woodward, W
    Bogardus, K
    Marquardt, W
    Shinto, L
    Morris, C
    Bourdette, D
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 159 - 165
12345